BAXTER INTERNATIONAL INC (BAX)
Surgical & Medical Instruments & Apparatus · Surgical & Medical Instruments & Apparatus · NYSE
$26.67
+2.79%
Investingg Score
37.5 / 100
Sell
Business overview
- Gross margin stands at 30.1% based on the provided metrics.
- Operating margin is negative at -2.7%.
These figures demonstrate that while the core business retains a moderate gross profit level, operational costs currently overwhelm earnings generation.
Financial health
- Free cash flow margin is recorded at 3%. Data unavailable for additional detailed balance sheet metrics.
This low cash flow margin indicates limited internal cash generation relative to revenue, introducing uncertainty regarding financial resilience.
- Gross Margin
- 30.1%
- Operating Margin
- -2.7%
- Current Ratio
- 2.3x
- Debt / Equity
- 1.54
- Free Cash Flow (TTM)
- $0.3B
- Interest Coverage
- -1x
Valuation
- Forward P/E ratio is positioned at 13.57.
- EV to EBITDA ratio stands at 7.28, with P/E and P/S ratios currently unavailable.
These valuation multiples suggest the stock is priced moderately relative to forward earnings and EBITDA, though limited historical context adds uncertainty.
- P/E (TTM)
- Data unavailable
- Forward P/E
- 13.6x
- Price / Sales
- 0.0x
- EV / EBITDA
- 7.3x
- FCF Yield
- Data unavailable
Key risks
- Negative operating margin of -2.7% highlights ongoing core operational challenges.
- Sharp year-over-year EPS decline of -47.2% points to severe bottom-line vulnerability.
- Low free cash flow margin of 3% restricts financial flexibility.
Market cap $0 · data as of 2026-08-19
Related stocks
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze BAX with Investingg AINot investment advice. Investingg AI summarizes public data and AI-generated analysis for informational purposes only.